Nucana PLC (NCNA) — SEC Filings
Nucana PLC (NCNA) — 44 SEC filings. Latest: 6-K (Dec 17, 2025). Includes 38 6-K, 3 SC 13G/A, 2 20-F.
Overview
Nucana PLC (NCNA) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Dec 10, 2025: On December 10, 2025, NuCana plc announced the presentation of new clinical data from patients treated with their drug. The press release was filed as a Form 6-K with the SEC.
Sentiment Summary
Across 44 filings, the sentiment breakdown is: 1 bullish, 2 bearish, 41 neutral. The dominant filing sentiment for Nucana PLC is neutral.
Filing Type Overview
Nucana PLC (NCNA) has filed 38 6-K, 2 20-F, 3 SC 13G/A, 1 SC 13D/A with the SEC between Jan 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (44)
Risk Profile
Risk Assessment: Of NCNA's 39 recent filings, 0 were flagged as high-risk, 16 as medium-risk, and 23 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Key Executives
- Hugh S. Griffith
- Donald Munoz
- Dr. James I. Healy
- Dr. Maha Katabi
Industry Context
NuCana plc operates within the pharmaceutical preparations industry.
Top Tags
financial-results (6) · pharmaceuticals (6) · filing (5) · sec-filing (5) · annual-report (5) · 6-K (4) · clinical-data (3) · press-release (3) · biotech (3) · clinical-trial-data (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Reporting Period | Q2 2025 | Financials for the second quarter of 2025 are detailed. |
| Potential Capital Raise | $50.0M | Maximum amount NuCana plc can raise through the Sales Agreement |
| Consecutive business days | 30 | Below minimum bid price for Nasdaq listing |
| Fiscal Year End | 2024-12-31 | Reporting period for the 20-F |
| Filing Date | 2025-03-20 | Date the 20-F was submitted to the SEC |
| Days to regain compliance | 180 | NuCana plc has 180 days to meet Nasdaq's minimum bid price requirement. |
| Nominal Value per Share | £0.04 | Nominal value of NuCana plc's ordinary shares |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Nucana PLC (NCNA)?
Nucana PLC has 44 recent SEC filings from Jan 2024 to Dec 2025, including 38 6-K, 3 SC 13G/A, 2 20-F. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of NCNA filings?
Across 44 filings, the sentiment breakdown is: 1 bullish, 2 bearish, 41 neutral. The dominant sentiment is neutral.
Where can I find Nucana PLC SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Nucana PLC (NCNA) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Nucana PLC?
Financial highlights for Nucana PLC are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for NCNA?
The investment thesis for NCNA includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Nucana PLC?
Key executives identified across Nucana PLC's filings include Hugh S. Griffith, Donald Munoz, Dr. James I. Healy, Dr. Maha Katabi.
What are the main risk factors for Nucana PLC stock?
Of NCNA's 39 assessed filings, 0 were flagged high-risk, 16 medium-risk, and 23 low-risk.
What are recent predictions and forward guidance from Nucana PLC?
Forward guidance and predictions for Nucana PLC are extracted from SEC filings as they are enriched.